
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors
Keywords: Benzothiopyranopyrimidines; KDR kinase; Antiproliferative activity; Kinase inhibitors; A-431; epidermoid carcinoma cell line; DMEDA; N,Nâ²-dimethylethylendiamine; HeLa; cervix adenocarcinoma cell line; h; human; HUVEC; human umbilical vein endothelial ce